Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
- DOI
- 10.1016/j.esmoop.2021.100101
- Published
- 2021 Jun
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2021.100101,
title = {Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.},
author = {Choueiri TK and Larkin J and Pal S and Motzer RJ and Rini BI and Venugopal B and Alekseev B and Miyake H and Gravis G and Bilen MA and Hariharan S and Chudnovsky A and Ching KA and Mu XJ and Mariani M and Robbins PB and Huang B and di Pietro A and Albiges L},
year = {2021},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2021.100101},
url = {https://doi.org/10.1016/j.esmoop.2021.100101}
}RIS
TY - JOUR TI - Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial. AU - Choueiri TK AU - Larkin J AU - Pal S AU - Motzer RJ AU - Rini BI AU - Venugopal B AU - Alekseev B AU - Miyake H AU - Gravis G AU - Bilen MA AU - Hariharan S AU - Chudnovsky A AU - Ching KA AU - Mu XJ AU - Mariani M AU - Robbins PB AU - Huang B AU - di Pietro A AU - Albiges L PY - 2021 JO - ESMO open DO - 10.1016/j.esmoop.2021.100101 UR - https://doi.org/10.1016/j.esmoop.2021.100101 ER -
APA
TK, C., J, L., S, P., RJ, M., BI, R., B, V., B, A., H, M., G, G., MA, B., S, H., A, C., KA, C., XJ, M., M, M., PB, R., B, H., A, D. P., & L, A. (2021). Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.. ESMO open. https://doi.org/10.1016/j.esmoop.2021.100101
Source records
- pubmed · retrieved 2026-09-26T13:30:42.749Z
- europe-pmc · retrieved 2026-09-26T13:30:42.748Z